JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M010059200 on January 8, 2001

J. Biol. Chem., Vol. 276, Issue 14, 11049-11054, April 6, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/14/11049    most recent
M010059200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linderoth, N. A.
Right arrow Articles by Sastry, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linderoth, N. A.
Right arrow Articles by Sastry, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Binding of Antigenic Peptide to the Endoplasmic Reticulum-resident Protein gp96/GRP94 Heat Shock Chaperone Occurs in Higher Order Complexes
ESSENTIAL ROLE OF SOME AROMATIC AMINO ACID RESIDUES IN THE PEPTIDE-BINDING SITE*

Nora A. LinderothDagger , Martha N. Simon§, James F. Hainfeld§, and Srin SastryDagger

From the Dagger  Laboratory of Molecular Genetics, The Rockefeller University, New York, New York 10021 and the § Department of Biology, Brookhaven National Laboratory, Upton, New York 11973

Vaccination with heat shock protein gp96-antigenic peptide complexes produces a powerful specific immune response against cancers and infectious diseases in some experimental animal models, and gp96-peptide complexes are now being tested in human clinical trials. gp96 appears to serve as a natural adjuvant for chaperoning antigenic peptides into the immune surveillance pathways. A fundamental issue that needs to be addressed is the mechanism of binding of antigenic peptide to gp96. Here, we show using scanning transmission electron microscopy that recombinant gp96 binds peptide in stable multimeric complexes, which may have biological significance. To open the possibility for genetically engineering gp96 for improved immunogenicity and to understand if molecular recognition plays a role in the binding of antigenic peptide, we mutagenized some specific aromatic amino acids in the presumed peptide-binding pocket. Replacement of Tyr-667 or Tyr-678 to Ala reduced affinity for peptide whereas conversion of Trp-654 to Tyr increased peptide binding. Similarly, changing Trp-621 to Phe or Leu or Ala or Ile negatively affected peptide binding whereas changing Trp-621 to Tyr or Val positively affected peptide binding. Probing the peptide microenvironment in gp96-peptide complexes, suggested that hydrophobic interactions (and perhaps hydrogen bonding/stacking interactions) may play a role in peptide loading by gp96.


* This work was supported in part by grants from the Cancer Research Inst., NY, Antigenics L.L.C, NY, Hewlett Packard Foundation (to S. S.), and Grant P41-RR01777 from the National Institutes of Health and the United States Department of Energy Office of Biological and Environmental Research (to M. N. S. and J. F. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Laboratory of Molecular Genetics, Box 174, The Rockefeller University, 1230 York Ave., New York, NY 10021. E-mail: sastrys@rockvax.rockefeller.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
C. Biswas, U. Sriram, B. Ciric, O. Ostrovsky, S. Gallucci, and Y. Argon
The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells
Int. Immunol., July 1, 2006; 18(7): 1147 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Suriano, S. K. Ghosh, B. T. Ashok, A. Mittelman, Y. Chen, A. Banerjee, and R. K. Tiwari
Differences in Glycosylation Patterns of Heat Shock Protein, gp96: Implications for Prostate Cancer Prevention
Cancer Res., July 15, 2005; 65(14): 6466 - 6475.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Demine and P. Walden
Testing the Role of gp96 as Peptide Chaperone in Antigen Processing
J. Biol. Chem., May 6, 2005; 280(18): 17573 - 17578.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Vogen, T. Gidalevitz, C. Biswas, B. B. Simen, E. Stein, F. Gulmen, and Y. Argon
Radicicol-sensitive Peptide Binding to the N-terminal Portion of GRP94
J. Biol. Chem., October 18, 2002; 277(43): 40742 - 40750.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.